Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1373-1376

  Nacsa, Janos ^a   Nagy, Laszlo ^b   Molnar, Joseph ^a   Molnar, Janos ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Metal complex; Moloney murine leukemia virus; Phenothiazine; Retrovirus; Reverse transcriptase; Trifluoperazine

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TRIFLUOPERAZINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; COPPER; KINETICS; METALS; MICE; MOLONEY MURINE LEUKEMIA VIRUS; NICKEL; ORGANOMETALLIC COMPOUNDS; PALLADIUM; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; TIN; TRIFLUOPERAZINE;

EID: 0031855572     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fauci A S: The Human Immunodeficiency Virus: Infectivity and Mechanism of Pathogenesis. Science 239: 617-622, 1988.
2. Mitsuya H, Yarchoan R, Broder S: Molecular targets for AIDS therapy. Science 249: 1533-1544, 1990.
3. Sarin P S: Molecular Pharmacologic approaches to the treatment of AIDS. Annu Rev Pharmacol 28: 411-428, 1988.
4. Tisdale M, Alnadaf T, Cousens D: Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89. Antimicrob Agents Chemother 41(5): 1094-1098, 1997.
5. Krebs R, Immendorfer U, Thrall SH, Wohrl BM, Goody RS: Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Biochemistry 36(33): 10292-10300, 1997.
6. Loya S, Bakhanashvili M, Kashman Y and Hizi A: Mechanism of inhibition of HIV reverse transcriptase by Toxiusol, a novel general inhibitor of retroviral and cellular DNA Polymerases. Biochemistry 34: 2260-2266, 1995.
7. Nagy L, Korecz L7 Kiricsi I, Zsikla L, Burger K: Synthesis, Mossbauer and IR spectroscopic studies and thermal behavior of organotin(IV) complexes with carbohydrate ligands. Struct Chem 2: 231-238, 1991.
8. Lambrecht B, Mohr H, Knuver-Hopf J, Schmitt H: Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox-Sang 60(4): 207-213, 1991.
9. Schafer W, Friebe W-G, Leinert H, Mertens A, Poll T, von der Saal W, Zilch H, Nuber B, Ziegler M L: Non-nucleoside inhibitors of HIV-1 reverse transcriptase: Molecular modeling and X-ray structure investigation. J Med Chem 36: 726-732, 1993.
10. Artico M, Silvestri R, Pagnozzi E, Stefancich G, Massa S, Loi AG, Putzolu M, Corrias S, Spiga MG, La-Colla P: 5H-pyrrolo[1,2-b] [1,'7,5]benzothiadiazepines (PBTDs): a novel class of non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 4(6): 837-850, 1996.
11. Filler AG, Lever AM: Effects of cation substitutions on reverse transcriptase and on human immunodeficiency virus production. AIDS Res Hum Retroviruses 13(4): 291-299, 1997.
12. Bruno G, Cusumano M, Giannetto A, Zappala M, Nicoloo F, Romeo R: Synthesis and characterization in solid and solution oftrans dichloro-1-(2', 6'-difluorophenyl)-1H,3H-thiazolo [3,4-a]-benzimidazole(tri-n-propyl-phosphine)-palladium(II): a palladium(II) complex of a ligand with anti-HIV properties. J Inorg Biochem 65(2): 97-102, 1997.
13. Kidd S, Nelson MJ, Epstein M, Aszalos A, Pine S, Molnár J: Inhibition of gp120 and antibodies binding to CD4 by metal complexes of promazines. Antiinfective Drugs and Chemotherapy 15 (2/3): 71 -77, 1997.